NCT03294408

Brief Summary

Predictive factors of osteoarthritis progression are not yet well understood. However, a growing role attaches importance to the subchondral bone. The aim of the present project is to determine predictive factors of progression of osteoarthritis at the knee by a multimodal characterization of subchondral bone by Medical Resonnance Imaging, direct high resolution digitization radiographs and bone texture analysis. At the end of the project, an innovative imaging device, combining semi-automatic softwares for texture analysis, control detection and image registration would be supplied. This will enable on the one hand a more accurate and reproducible way to measure the joint space width of the affected compartment and on the other hand, an assistance to better detect patients at risk of progression of their knee osteoarthritis. Identifying These "progressors" patients might permit their selection in clinical trials at baseline adapted to their severe disease, using for example biologic treatments targeting knee osteoarthritis. The main objective of this study is to analyze the predictive capacities of bone texture parameters measured on the high-resolution radiography of the knee on the structural evolution of the knee osteoarthritis at 3 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
167

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
Completed

Started Nov 2016

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 29, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 4, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 27, 2017

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 19, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2023

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

6.6 years

First QC Date

July 4, 2017

Last Update Submit

November 26, 2025

Conditions

Keywords

fractal analysistrabecular bone textureknee osteoarthritissubchondral boneMedical Resonnance Imaging

Outcome Measures

Primary Outcomes (3)

  • Proportion of patients who have one-point increase in the quality score of OARSI

    Patients who over the 3-year follow-up period will have a one-point increase in the quality score of OARSI compared to the initial pinch score (Altman RD et al, Osteoarthritis and Cartilage 1995).

    3 years

  • Proportion of patients whose joint space reduction is greater than the smallest reliable detectable difference.

    Patients whose joint space reduction is greater than the smallest reliable detectable difference.

    3 years

  • Proportion of patients who have a decrease in joint space of 0.5 mm

    Patients who have a decrease in joint space of 0.5 mm or more over the 3-year period (Cooper C et al, CMRO 2012).

    3 years

Secondary Outcomes (6)

  • Proportion of patients who have evolution of medial femoral tibial joint space

    3 years

  • Number of particpants who will have evolution of strucutral lesion score

    3 years

  • Evolution of algo-functional scores (OAKHQOL)

    3 years

  • Evolution of algo-functional scores (WOMAC)

    3 years

  • Change From Baseline in quality of life Scores

    3 years

  • +1 more secondary outcomes

Study Arms (1)

Imaging

OTHER

multimodal imaging and clinical assessment

Diagnostic Test: multimodal imaging

Interventions

multimodal imagingDIAGNOSTIC_TEST
Also known as: clinical assessment
Imaging

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • knee osteoarthritis according to the criteria of knee osteoarthritis of American College of Rheumatology.
  • Having felt a painful push in the last 6 months.
  • Visual Analogic Scale pain \> 4 on a 0 to 10 scale.
  • having a Radiographic score of OARSI (Osteoarthritis Research Society International Score) from 2 to 3 whether it is for the presence of a joint space narrowing or the presence of an osteophyte

You may not qualify if:

  • Patello-femoral degenerative osteoarthritis isolated.
  • Incapacitated to consider the position in schuss for the realization of the radiography.
  • Valgus \> in 5 °
  • Secondary degenerative osteoarthritis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Chu Brabois

Nancy, 54511, France

Location

CHR Orléans

Orléans, 45067, France

Location

Related Publications (5)

  • Janvier T, Jennane R, Valery A, Harrar K, Delplanque M, Lelong C, Loeuille D, Toumi H, Lespessailles E. Subchondral tibial bone texture analysis predicts knee osteoarthritis progression: data from the Osteoarthritis Initiative: Tibial bone texture & knee OA progression. Osteoarthritis Cartilage. 2017 Feb;25(2):259-266. doi: 10.1016/j.joca.2016.10.005. Epub 2016 Oct 11.

    PMID: 27742531BACKGROUND
  • Arden N, Richette P, Cooper C, Bruyere O, Abadie E, Branco J, Brandi ML, Berenbaum F, Clerc C, Dennison E, Devogelaer JP, Hochberg M, D'Hooghe P, Herrero-Beaumont G, Kanis JA, Laslop A, Leblanc V, Maggi S, Mautone G, Pelletier JP, Petit-Dop F, Reiter-Niesert S, Rizzoli R, Rovati L, Tajana Messi E, Tsouderos Y, Martel-Pelletier J, Reginster JY. Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty. Drugs Aging. 2015 Jul;32(7):525-35. doi: 10.1007/s40266-015-0276-7.

    PMID: 26085027BACKGROUND
  • Woloszynski T, Podsiadlo P, Stachowiak GW, Kurzynski M, Lohmander LS, Englund M. Prediction of progression of radiographic knee osteoarthritis using tibial trabecular bone texture. Arthritis Rheum. 2012 Mar;64(3):688-95. doi: 10.1002/art.33410.

    PMID: 21989629BACKGROUND
  • Guermazi A, Roemer FW, Felson DT, Brandt KD. Motion for debate: osteoarthritis clinical trials have not identified efficacious therapies because traditional imaging outcome measures are inadequate. Arthritis Rheum. 2013 Nov;65(11):2748-58. doi: 10.1002/art.38086. No abstract available.

    PMID: 23861096BACKGROUND
  • Kraus VB, Feng S, Wang S, White S, Ainslie M, Brett A, Holmes A, Charles HC. Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression. Arthritis Rheum. 2009 Dec;60(12):3711-22. doi: 10.1002/art.25012.

    PMID: 19950282BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, KneeJoint DiseasesArthritisMusculoskeletal Diseases

Interventions

Multimodal Imaging

Condition Hierarchy (Ancestors)

OsteoarthritisRheumatic Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Eric LESPESSAILLES, Dr

    CHR Orléans

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Interventional study among patients suffering from knee osteoarthritis for at least six months. All the patients will benefit from a multimodal imaging and clinical assessment.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2017

First Posted

September 27, 2017

Study Start

November 29, 2016

Primary Completion

June 19, 2023

Study Completion

June 19, 2023

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations